NOVA CRU Rua do Instituto Bacteriológico, nº5, 2º piso 1150-082 Lisboa, Portugal
Telefone: 914006726 Ext: 27002

Teresa Catarina Páscoa Madeira

Investigador  Investigador Auxiliar Convidado
Catarina is currently Senior Clinical Research Manager at NOVA CRU and a Researcher at CHRC at NMS. Until recently, Catarina was the Portuguese European Correspondent for clinical research at ECRIN (European Clinical Research Infrastructure Network), focused on coordinating ongoing multinational clinical trials in Portugal and providing support to national clinical investigators preparing clinical studies/projects for European funding. She also actively contributed to the development of the national network, PtCRIN (Portuguese Clinical Research Infrastructure Network) (2015-2019). Previously Catarina worked in the Institute for Biotechnology and Bioengineering in Lisbon as a research scientist in the field of regenerative medicine (RM). She supervised several post-graduation students (M.Sc and Ph.D.) and is (co)author of more than 30 scientific papers published in peer-reviewed journals. She has contributed to several national and international Workshops, M.Sc and Ph.D. programs lecturing about clinical trials, regulatory affairs, clinical project management and advanced therapy medicinal products (ATMPs). Catarina received a B.Sc in technological chemistry from Sciences Faculty, an M.Sc and Ph.D. in biotechnology from Instituto Superior Técnico, all from the University of Lisbon. She also did a post-graduation program in clinical trials and got a Project Management Professional (PMP) certification from the Project Management Institute (USA).
* Andrade, M.; Matias, D.; Batuca, J.; Gouveia, N.; Mota-Filipe, H.; Monteiro, E.C.; Madeira, C., Portuguese Authorship in published clinical trials: differences in Industry and Investigator-Initiated Trial”s. Ata Médica Portuguesa. 2021 accepted for publication. doi: 10.20344/amp.14554 * Madeira, C., Hořavová, L., dos Santos, F. et al. Investigator-Initiated Clinical Trials (IICTs): A Systematic Search in Registries to Compare the Czech Republic and Portugal in Terms of Funding Policies and Scientific Outcomes. Ther Innov & Regul Sci , 2021. 966–978. doi: 10.1007/s43441-021-00293-w * Madeira C. , dos Santos, F., Kubiak, C., Demotes, J., Monteiro. EC, Transparency and accuracy in funding investigator-initiated clinical trials: a systematic search in clinical trials databases. BMJ Open. 2019. 9:e023394; Doi: org/10.1136/bmjopen-2018-023394 * Ferro, T., Santhagunam, A, Madeira, C, Salgueiro, J.B., da Silva, C.L:, Cabral, J.C. Successful isolation and ex vivo expansion of human mesenchymal stem/stromal cells obtained from different synovial tissue‐derived (biopsy) samples. Journal of cellular physiology. 2019. 234(4):3973-3984; doi: 10.1002/jcp.27202 * Madeira, C., Pais, A., Kubiak, C., Demotes, J., Monteiro, E.C., Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN). Contemporary Clinical Trials Communications. 2016). 4: 141-148; doi: 10.1016/j.conctc.2016.08.002 * Madeira, C., Santhagunam, A., Salgueiro, J.B., Cabral, J.M.S. Advanced cell therapies for articular cartilage regeneration. Trends in Biotechnology. 2015. 33(1): 35–42. doi: 10.1016/j.tibtech.2014.11.003
* João Porto Scholarship of the Portuguese Society of Cardiology: The team “Salgueiro, A.M., Fiarresga, A., da Silva, C.L., Madeira, C., Cabral, J.M.S.” was awarded the “João Porto” Scholarship of the Portuguese Society of Cardiology (PSC – 2013) for the project “Stem Cell Engineering in Allogeneic Cell-Based Therapies for Myocardial Regeneration”.
ORCID: 0000-0002-5053-9421 Scopus Author ID: 10739770400 Ciência ID: 5115-3E6A-5506